RxDoctor Payments Data

Jay Connelley, MD

Family Medicine · Monticello, ARNPI 1649250689

Payments from drug & device makers

$6,785in general payments, 2019–2025

Across 404 payments — averaging $16.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • GSK$1K
  • AstraZeneca$951
  • Novo Nordisk$402
  • Pfizer$300
  • Bayer$265
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$6,778100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,785 in reported general payments places this provider in the 90th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$238,721
Medicare patients
410
Services billed
3,814

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin193$183,441
EliquisApixaban197$162,929
OzempicSemaglutide80$100,800
MounjaroTirzepatide70$75,439
Trelegy ElliptaFluticasone/Umeclidin/Vilanter87$69,215
Breztri AerosphereBudesonide/Glycopyr/Formoterol76$61,386
FarxigaDapagliflozin Propanediol75$59,354
LinzessLinaclotide55$52,811
XareltoRivaroxaban59$49,758
KerendiaFinerenone60$42,750
TrulicityDulaglutide31$40,568
RybelsusSemaglutide29$28,335
JanuviaSitagliptin Phosphate34$25,115
ProliaDenosumab14$25,021
TradjentaLinagliptin29$22,007

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$219$205,448222 claims
PfizerEliquis, Premarin$300$167,355212 claims
Novo NordiskOzempic, Rybelsus$402$129,135109 claims
AstraZenecaBreztri Aerosphere, Farxiga$951$120,740151 claims
Lilly USA, LLCMounjaro, Trulicity$164$116,007101 claims
GSKTrelegy Ellipta, Anoro Ellipta$1,223$81,512107 claims
AbbVieLinzess, Fetzima$1,425$58,23566 claims
Johnson & JohnsonXarelto$64$49,75859 claims
BayerKerendia$265$42,75060 claims
MerckJanuvia$111$25,11534 claims
AmgenProlia$94$25,02114 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$73$17,13218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Monticello

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →